SAN FRANCISCO - A plaintiff in an Aredia/Zometa products liability action failed to present reliable expert testimony linking the drugs to her osteonecrosis of the jaw (ONJ), a federal judge in California held Feb. 15 in granting summary judgment to the defendant drug manufacturer, Novartis Pharmaceuticals (Linda Messick v. Novartis Pharmaceuticals, Corp., No. CV 12-00693, N.D. Calif.; 2013 U.S. Dist. LEXIS 21251)....(read more)![]()
↧